Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder Read more
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Read more
Nordic Capital acquires speciality pharmaceutical company ADVANZ PHARMA in deal worth ~ $846 million Read more
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China Read more
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services Read more
Key updates ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference in three weeks! Read more